Checks for hidden small airways blockage in cystic fibrosis
Part of Lungs & breathing clinical trials.
This trial looks for early, “hidden” breathing test abnormalities in people with cystic fibrosis who have normal routine lung test results. It may help researchers find blockage in smaller airways before it shows up on standard tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of cystic fibrosis.
- Your routine breathing test (spirometry) done before a bronchodilator shows normal results.
- Your lung volume/strength measures are normal: FEV1 and FVC.
- Your ratio of airflow (FEV1/FVC) is normal.
- You should not have abnormal spirometry results before using a bronchodilator.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares physical abilities between children with cystic fibrosis and healthy children. It aims to find differences that could lead to better care and therapies.
This study uses a special MRI that can show inflammation in the lungs. It looks at healthy children and children with mild cystic fibrosis to test if the scan can detect early changes. If you join, you will breathe in a special gas during the MRI.
This study tests a new method to detect bacteria in the lungs of people with cystic fibrosis (CF) by analyzing mucus samples. It aims to improve how we diagnose and treat lung infections.
This trial studies how well a non-invasive lung test can show lung involvement in people with asthma (especially IgE-related asthma) and people with cystic fibrosis. You might benefit by getting extra lung assessments without invasive procedures.
This study looks for simple signals (markers) that may show whether cystic fibrosis treatments are working. It includes people who take CF “modulator” medicines like ivacaftor, people who don’t, and people whose cystic fibrosis was ruled out after testing.
This study looks at how a child’s early lung function, viral infections, and gut (microbiome) changes affect cystic fibrosis over time. It may help doctors understand what predicts how lung disease develops, which could improve future care.
Hear when a new Cystic Fibrosis in Children trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.